BDSX
BIODESIX INC
Key Financials
Revenue
$88.5M
↑ 24.1%
Net Income
$-35265000
↑ 17.9%
Operating Income
$-27873000
↑ 19.2%
Total Assets
$87.5M
↓ 10.0%
EPS (Diluted)
$-4.67
↓ 1315.2%
Total Liabilities
$89.9M
↑ 17.8%
Cash & Equivalents
$19.0M
↓ 27.7%
Shareholders' Equity
$-2465000.00
↓ 111.8%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | BDSX |
| Company Name | BIODESIX INC |
| CIK | 1439725 |
| SIC Code | 8071 |
| SIC Description | Services-Medical Laboratories |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 303-417-0500 |